AAAAAA
Results:
1-13
|
Results: 13
Authors:
FISH DN
BEALL HD
GOODWIN SD
FOX JL
Citation: Dn. Fish et al., STABILITY OF SUMATRIPTAN SUCCINATE IN EXTEMPORANEOUSLY PREPARED ORAL LIQUIDS, American journal of health-system pharmacy, 54(14), 1997, pp. 1619-1622
Authors:
LIU CT
KIJEK TM
ROSSI CA
BUSHE TK
CARPENTER CB
GOODWIN SD
HAIL A
CREASIA DA
WALTERS DM
DINTERMAN RE
MEREISH KA
Citation: Ct. Liu et al., STAPHYLOCOCCAL-ENTEROTOXIN-B (SEB) KINETICS AFTER INTRATRACHEAL (IT) INSTILLATION IN DUTCH RABBITS, The FASEB journal, 10(3), 1996, pp. 1010-1010
Authors:
GOODWIN SD
HAMILTON HJ
Citation: Sd. Goodwin et Hj. Hamilton, ITS ABOUT TIME - AN INTRODUCTION TO THE SPECIAL ISSUE ON TEMPORAL REPRESENTATION AND REASONING, Computational intelligence, 12(3), 1996, pp. 357-358
Authors:
SCHUMOCK GT
MEEK PD
PLOETZ PA
VERMEULEN LC
ALLDREDGE B
AMSDEN G
ANDERSON D
BEDNARCZYK E
GOODWIN SD
JABER L
KNOPPERT D
MUELLER B
OTTO M
POIRIER T
RHO J
SCHEIFE R
SMYTHE M
THOMAS W
THOMPSON D
UDEN D
VASQUEZ E
Citation: Gt. Schumock et al., ECONOMIC EVALUATIONS OF CLINICAL PHARMACY SERVICES - 1988-1995, Pharmacotherapy, 16(6), 1996, pp. 1188-1208
Authors:
VOGEL P
ZAUCHA G
GOODWIN SD
KUEHL K
FRITZ D
Citation: P. Vogel et al., RAPID POSTMORTEM INVASION OF CECAL MUCOSA OF MACAQUES BY NONPATHOGENIC ENTAMOEBA-CHATTONI, The American journal of tropical medicine and hygiene, 55(6), 1996, pp. 595-602
Authors:
GOODWIN SD
FISH DN
Citation: Sd. Goodwin et Dn. Fish, CRITERIA FOR USE OF ATOVAQUONE ORAL SUSPENSION IN ADULT INPATIENTS AND OUTPATIENTS, American journal of health-system pharmacy, 52(21), 1995, pp. 2460-2462
Authors:
GOODWIN SD
CLEARY JD
WALAWANDER CA
TAYLOR JW
GRASELA TH
Citation: Sd. Goodwin et al., PRETREATMENT REGIMENS FOR ADVERSE EVENTS RELATED TO INFUSION OF AMPHOTERICIN-B, Clinical infectious diseases, 20(4), 1995, pp. 755-761
USE OF ANTIFUNGAL THERAPY IN HOSPITALIZED-PATIENTS .1. RESULTS PRIOR TO THE MARKETING OF FLUCONAZOLE
Authors:
GRASELA TH
GOODWIN SD
PASKO MT
WALAWANDER CA
RAEBEL MA
Citation: Th. Grasela et al., USE OF ANTIFUNGAL THERAPY IN HOSPITALIZED-PATIENTS .1. RESULTS PRIOR TO THE MARKETING OF FLUCONAZOLE, The Annals of pharmacotherapy, 28(2), 1994, pp. 252-260
Authors:
GRASELA TH
PASKO MT
GOODWIN SD
WALAWANDER CA
BLACKWELDER N
BRUDERHOLT RJ
Citation: Th. Grasela et al., USE OF ANTIFUNGAL THERAPY IN HOSPITALIZED-PATIENTS .2. RESULTS AFTER THE MARKETING OF FLUCONAZOLE, The Annals of pharmacotherapy, 28(2), 1994, pp. 261-270
Authors:
GOODWIN SD
MAHROOS M
NEUFELD E
Citation: Sd. Goodwin et al., IDNAF PROLOG, Applied mathematics letters, 7(3), 1994, pp. 13-16
Authors:
GOODWIN SD
GALLIS HA
CHOW AT
WONG FA
FLOR SC
BARTLETT JA
Citation: Sd. Goodwin et al., PHARMACOKINETICS AND SAFETY OF LEVOFLOXACIN IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 799-804
Authors:
GOODWIN SD
Citation: Sd. Goodwin, PNEUMOCYSTIS-CARINII PNEUMONIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INFANTS AND CHILDREN, Pharmacotherapy, 13(6), 1993, pp. 640-646
Authors:
GOODWIN SD
FUS A
HATTON RC
SHWED JA
Citation: Sd. Goodwin et al., PHARMACISTS AND THE PHARMACEUTICAL-INDUSTRY - GUIDELINES FOR ETHICAL INTERACTIONS, Pharmacotherapy, 13(5), 1993, pp. 531-533
Risultati:
1-13
|